The Technical Analyst
Select Language :
Champions Oncology Inc [CSBR]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Champions Oncology Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Champions Oncology Inc is listed at the  Exchange

-2.58% $4.90

America/New_York / 28 mar 2024 @ 16:00


Champions Oncology Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 66.61 mill
EPS: -0.720
P/E: -6.81
Earnings Date: Mar 14, 2024
SharesOutstanding: 13.59 mill
Avg Daily Volume: 0.0084 mill
RATING 2024-03-28
B-
Sell
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Buy
Return On Asset: Neutral
DE: Strong Sell
P/E: Strong Sell
Price To Book: Strong Sell
QUARTER GROWTHS
4/221/232/233/234/231/24
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -6.81 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-1.16x
Company: PE -6.81 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$1.966
(-59.87%) $-2.93
Date: 2024-03-29
Expected Trading Range (DAY)

$ 4.62 - 5.18

( +/- 5.80%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-01-12 Mendelson Daniel Newman Buy 1 000 Common Stock
2024-01-11 Mendelson Daniel Newman Buy 2 000 Common Stock
2024-01-10 Mendelson Daniel Newman Buy 2 944 Common Stock
2024-01-09 Mendelson Daniel Newman Buy 3 000 Common Stock
2024-01-08 Mendelson Daniel Newman Buy 1 000 Common Stock
INSIDER POWER
82.73
Last 100 transactions
Buy: 1 043 632 | Sell: 506 980

Forecast: 16:00 - $4.91

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
Volume Signals
Price $4.90 (-2.58% )
Volume 0.0034 mill
Avg. Vol. 0.0084 mill
% of Avg. Vol 40.22 %
Signal 1:

Today

Intraday chart data with high, low, open and close for Champions Oncology Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Champions Oncology Inc

RSI

Last 10 Buy & Sell Signals For CSBR

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Champions Oncology Inc

CSBR

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company provides Lumin Bioinformatics, a software platform and data tool that contains comprehensive information derived from research services and clinical studies, and sold on an annual subscriptions basis. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Last 10 Buy Signals

Date Signal @
SUPERUSDMar 29 - 09:34$1.359
UQCUSDMar 29 - 06:54$7.20
BNBUSDMar 29 - 09:31$615.19
TIMEUSDMar 29 - 09:3232.37
AGLDUSDMar 29 - 09:301.650
MINAUSDMar 29 - 09:29$1.238
CBKUSDMar 29 - 09:281.087
METAMar 28 - 16:00$485.58
MSTRMar 28 - 16:00$1 704.56
STORJUSDMar 29 - 09:26$0.817

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.